Head to Head Review: BioRestorative Therapies (OTCMKTS:BRTX) and Convey Holding Parent (NYSE:CNVY)

BioRestorative Therapies (OTCMKTS:BRTX) and Convey Holding Parent (NYSE:CNVY) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their profitability, analyst recommendations, institutional ownership, risk, valuation, earnings and dividends.

Analyst Recommendations

This is a summary of current ratings and price targets for BioRestorative Therapies and Convey Holding Parent, as reported by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
BioRestorative Therapies 0 0 0 0 N/A
Convey Holding Parent 0 1 7 0 2.88

Convey Holding Parent has a consensus price target of $14.86, indicating a potential upside of 87.15%. Given Convey Holding Parent’s higher possible upside, analysts clearly believe Convey Holding Parent is more favorable than BioRestorative Therapies.

Valuation & Earnings

This table compares BioRestorative Therapies and Convey Holding Parent’s gross revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
BioRestorative Therapies $80,000.00 143.91 -$11.27 million N/A N/A
Convey Holding Parent $282.91 million 2.05 -$6.46 million N/A N/A

Convey Holding Parent has higher revenue and earnings than BioRestorative Therapies.

Insider & Institutional Ownership

0.1% of BioRestorative Therapies shares are held by institutional investors. Comparatively, 92.2% of Convey Holding Parent shares are held by institutional investors. 27.5% of BioRestorative Therapies shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Profitability

This table compares BioRestorative Therapies and Convey Holding Parent’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
BioRestorative Therapies -40,483.08% N/A -851.45%
Convey Holding Parent N/A N/A N/A

Summary

Convey Holding Parent beats BioRestorative Therapies on 7 of the 9 factors compared between the two stocks.

About BioRestorative Therapies

Biorestorative Therapies Inc. provides stem cell collections, storage, and treatment services. It intends to develop a laboratory, performing cellular characterization and culturing, therapeutic outcomes analysis, stem cell-related IP and stem cell collection and storage services. The firm is developing the following scientific programs: brtxDISC, which offers a non-surgical treatment for bulging and herniated discs and addresses the gap between non-invasive and invasive back procedures; and ThermoStem, which involves in the use of a cell-based, brown adipose tissue construct, treatment for metabolic disease, such as type 2 diabetes, obesity, hypertension, and other metabolic disorders, as well as cardiac deficiencies. Its products are sold under the BRTX-100, ThermoStem and Stem Pearls as its trademarks. The company was founded on June 13, 1997 and is headquartered in Melville, NY.

About Convey Holding Parent

Convey Holding Parent, Inc., together with its subsidiaries, provides technology enabled solutions and advisory services to assist its clients with workflows across product developments, sales, member experience, clinical management, core operations, and business intelligence and analytics in the United States. It operates through two segments, Technology Enabled Solutions and Advisory Services. The Technology Enabled Solutions segment offers technology solutions through web-based customizable application that is used to identify, track, and administer contractual services, or benefits provided under a client's plan to its Medicare and Medicaid beneficiaries. It also provides analytics over healthcare data to capture and assess gaps in risk documentation, quality, clinical care, and compliance. The company's software solutions for health plans include enrollment and billing technology, supplemental benefits solution, agent and broker management, membership and financial reconciliation, compliance monitoring, and data analytic solutions. The Advisory Services segment offers advisory services, including sales and marketing strategies, provider network strategies, compliance, star ratings, quality, clinical, pharmacy, analytics, and risk adjustment. The company serves government sponsored, medicare, medicaid, and provided sponsored plans, as well as pharmacy benefits managers. The company was founded in 2001 and is headquartered in Fort Lauderdale, Florida. Convey Holding Parent, Inc. is a subsidiary of TPG Cannes Aggregation, L.P.

Receive News & Ratings for BioRestorative Therapies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioRestorative Therapies and related companies with MarketBeat.com's FREE daily email newsletter.